SCHEMBL7673129

SCHEMBL7673129

CC1=NN=C(c2ccccc2O)[N]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.40
HSD17B10 Q99714 4/20 0.40
ALDH1A1 P00352 3/20 0.40
BCL2L1 Q07817 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
KMT2A Q03164 5/20 0.39
MAPK1 P28482 2/20 0.38
MAPT P10636 5/20 0.37
MEN1 O00255 4/20 0.37
KDM4E B2RXH2 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HTT P42858 1/20 0.37
IDO1 P14902 4/20 0.37
NFKB1 P19838 2/20 0.37
RAB9A P51151 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677308 0.79 NPC1 (0.42) HPGDHSD17B10ALDH1A1SMN1; SMN2MAPK1
SCHEMBL7674225 0.76 HSD11B1 (0.46) HPGDALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL7682750 0.73 ALDH1A1 (0.46) HPGDHSD17B10ALDH1A1SMN1; SMN2KMT2A
SCHEMBL7677536 0.71 MKNK1 (0.40) KMT2AMEN1NPC1GAATHRB
SCHEMBL11716356 0.67 ALDH1A1 (0.43) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL18319991 0.67 ALDH1A1 (0.43) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL30442890 0.67 ALDH1A1 (0.67) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL29623192 0.67 ALDH1A1 (0.67) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL28574 0.67 ALDH1A1 (0.67) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL12474058 0.65 ALDH1A1 (0.41) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed